CSIMarket
 
Biorestorative Therapies Inc   (BRTX)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Biorestorative Therapies Inc

Business Description


Biorestorative Therapies Inc. is a biotechnology company that focuses on the development of medical procedures using cell-based therapies. The company specializes in developing therapies to treat various diseases and conditions by utilizing the body*s own natural repair mechanisms.

Biorestorative Therapies Inc. was founded in 2011 and is headquartered in New York. The company*s primary focus is on developing and commercializing stem cell-based therapies to restore function and repair damaged tissues and organs.

The main area of focus for Biorestorative Therapies Inc. is regenerative medicine. Regenerative medicine is a branch of medicine that aims to restore or replace damaged or diseased tissues and organs. The company is utilizing advanced technologies to harness the power of stem cells and other cell-based therapies to achieve these goals.

One of the key products being developed by Biorestorative Therapies Inc. is the ThermoStem program. ThermoStem is a treatment that uses a patient*s own adipose (fat) derived stem cells to regenerate thermal burn injuries. This program is in the pre-clinical stage and has shown promising results in preclinical studies.

Another important program under development by Biorestorative Therapies Inc. is the brown fat program. Brown fat is a type of fat that burns calories to generate heat, and its activation has the potential to combat obesity and metabolic disorders. The company is working on developing a method to increase the amount of brown fat in the body, which could have significant therapeutic implications.

In addition to these programs, Biorestorative Therapies Inc. is also involved in the development of cell-based therapies for various other conditions like disc degeneration in the spine, metabolic disorders, and age-related muscle loss.

The company is actively engaged in research and development activities to advance its therapies through preclinical and clinical studies. Biorestorative Therapies Inc. works closely with leading scientists, researchers, and medical institutions to further its understanding and application of regenerative medicine.

Furthermore, the company has a strong commitment to regulatory compliance and ensures that its therapies are developed and tested in accordance with the highest safety and quality standards. Biorestorative Therapies Inc. aims to obtain regulatory approvals for its therapies and eventually make them available to patients worldwide.

Overall, Biorestorative Therapies Inc. is a biotechnology company dedicated to the development of innovative cell-based therapies to address a wide range of medical conditions. With a focus on regenerative medicine, the company aims to restore function and improve the quality of life for patients through the use of advanced stem cell technologies.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com